tetano
Editor, Senior Moderator
Pediatrics. 2019 Sep 2. pii: e20192478. doi: 10.1542/peds.2019-2478. [Epub ahead of print]
[h=1]Recommendations for Prevention and Control of Influenza in Children, 2019-2020.[/h] COMMITTEE ON INFECTIOUS DISEASES.
[h=3]Collaborators (14)[/h]
[h=3]Abstract[/h] This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019-2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.
Copyright ? 2019 by the American Academy of Pediatrics.
PMID: 31477606 DOI: 10.1542/peds.2019-2478
[h=1]Recommendations for Prevention and Control of Influenza in Children, 2019-2020.[/h] COMMITTEE ON INFECTIOUS DISEASES.
[h=3]Collaborators (14)[/h]
[h=3]Abstract[/h] This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2019-2020 season. The American Academy of Pediatrics continues to recommend routine influenza immunization of all children without medical contraindications, starting at 6 months of age. Any licensed, recommended, age-appropriate vaccine available can be administered, without preference of one product or formulation over another. Antiviral treatment of influenza with any licensed, recommended, age-appropriate influenza antiviral medication continues to be recommended for children with suspected or confirmed influenza, particularly those who are hospitalized, have severe or progressive disease, or have underlying conditions that increase their risk of complications of influenza.
Copyright ? 2019 by the American Academy of Pediatrics.
PMID: 31477606 DOI: 10.1542/peds.2019-2478